Table 1. Descriptive analysis of sociodemographic variables and variables of interest pre-phacoemulsification.
Clinical characteristic | Total | Bromfenac 0.09% | Nepafenac 0.1% | Diclofenac sodium 0.1% | P |
Sex, n (%) | |||||
M | 103 (42.4) | 38 (47.5) | 29 (37.2) | 36 (42.4) | 0.423 |
F | 140 (57.6) | 42 (52.5) | 49 (62.8) | 49 (57.6) | |
Age | 71.7±9.3 | 74.2±9.3 | 70.1±8.4 | 70.7±9.8 | 0.012 |
Nationality, n (%) | |||||
Spanish | 221 (90.9) | 77 (96.3) | 68 (87.2) | 76 (89.4) | 0.115 |
Foreign | 22 (9.1) | 3 (3.8) | 10 (12.8) | 9 (10.6) | |
Eye, n (%) | |||||
Right | 123 (51.0) | 34 (42.5) | 39 (51.3) | 50 (58.8) | 0.111 |
Left | 118 (49.0) | 46 (57.5) | 37 (48.7) | 35 (41.2) | |
Diabetes mellitus, n (%) | |||||
No | 169 (69.5) | 56 (70.0) | 54 (69.2) | 59 (69.4) | 0.994 |
Yes | 74 (30.5) | 24 (30.0) | 24 (30.8) | 26 (30.6) | |
Anaesthetic, n (%) | |||||
Topical | 146 (60.8) | 50 (62.5) | 52 (68.4) | 44 (52.4) | 0.108 |
Local | 94 (39.2) | 30 (37.5) | 24 (31.6) | 40 (47.6) | |
Pre-S average thickness | 269.7±28.2 | 267.0±34.9 | 272.5±24.7 | 269.6±24.1 | 0.481 |
Pre-S center thickness | 243.9±64.3 | 243.3±77.6 | 256.4±52.2 | 233.3±59.1 | 0.073 |
Pre-S total volume | 7.63±0.80 | 7.56±0.98 | 7.70±0.70 | 7.62±0.68 | 0.507 |
Visual acuity (basal) | 0.43±0.24 | 0.42±0.25 | 0.41±0.25 | 0.45±0.22 | 0.416 |
IOP (basal) | 19.21±6.65 | 18.81±6.42 | 19.20±5.19 | 19.60±7.95 | 0.751 |
Pre-S: Pre-surgery; IOP: Intraocular pressure. Patients treated with bromfenac 0.09%, nepafenac 0.1% and diclofenac sodium 0.1% eye drops.